FDA Inspection 1250816 — MSH Pharma Inc.
The FDA completed an inspection of MSH Pharma Inc. on Aug 23, 2024 in Mont-Saint-Hilaire. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mont-Saint-Hilaire (Canada)